Showing results (431-440 of 560) with videos related to
Sort By:
Pageof 56
The Journal of General Virology|November 21, 2007
Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon responseMegumi Tasaka, Naoya Sakamoto, Yoshie Itakura, et al.The Lancet. Gastroenterology & Hepatology|April 22, 2021
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trialTaku Kobayashi, Satoshi Motoya, Shiro Nakamura, et al.Inflammatory Bowel Diseases|October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.The Lancet. Gastroenterology & Hepatology|April 2, 2022
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyKatsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, et al.Journal of Gastroenterology and Hepatology|December 21, 2013
Use of capsule endoscopy in patients with Crohn's disease in Japan: a multicenter surveyMotohiro Esaki, Takayuki Matsumoto, Kenji Watanabe, et al.Journal of Crohn'S & Colitis|December 2, 2017
Efficacy of Endoscopic Balloon Dilation for Small Bowel Strictures in Patients With Crohn's Disease: A Nationwide, Multi-centre, Open-label, Prospective Cohort StudyFumihito Hirai, Akira Andoh, Fumiaki Ueno, et al.Virology|August 28, 2010
IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clonesGoki Suda, Naoya Sakamoto, Yasuhiro Itsui, et al.Antimicrobial Agents and Chemotherapy|March 30, 2011
Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infectionTakako Watanabe, Naoya Sakamoto, Mina Nakagawa, et al.The Journal of Biological Chemistry|August 1, 2008
Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activityTaisuke Sawada, Chiharu Nishiyama, Takuma Kishi, et al.Hepatology (Baltimore, Md.)|August 23, 2012
Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunitySayuri Nitta, Naoya Sakamoto, Mina Nakagawa, et al.Pageof 56